SCHEMBL4918209

SCHEMBL4918209

COc1ccccc1Cc1[c]ccc(Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.41
IDO1 P14902 2/20 0.40
TAAR1 Q96RJ0 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
AR P10275 1/20 0.39
ATM Q13315 1/20 0.39
IDH1 O75874 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KCNH2 Q12809 1/20 0.39
PSMD14 O00487 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3246008 0.79 IDO1 (0.46) ALDH1A1IDO1TAAR1SIGMAR1CHRM2
SCHEMBL3296809 0.72 IDO1 (0.61) ALDH1A1SMN1; SMN2LMNAIDO1TAAR1
SCHEMBL16601111 0.72 CALM1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL16321443 0.70 ALDH1A1 (0.56) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL27606369 0.70 LTA4H (0.45) ALDH1A1KDM4ESMN1; SMN2LMNAIDO1
SCHEMBL24631774 0.70 IDO1 (0.55) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL27828699 0.70 POLB (0.32)
SCHEMBL4917488 0.69 IDO1 (0.46) ALDH1A1KDM4ELMNAIDO1TAAR1
SCHEMBL10718395 0.69 APLNR (0.51) ALDH1A1KDM4EIDO1TAAR1HTT
SCHEMBL31556089 0.68 ALDH1A1 (0.53) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7453009-B2 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-11-18 US disclosed
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027134-A1 HYDROXYBIPHENYL CARBOXYLIC ACIDS AND DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE GPR119, HACL2, HCAR2 ALDH1A1 495/4885KDM4E 4060/4885MEN1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.